Article
Serum 25(OH)D3 levels affect treatment outcomes for telaprevir/peg-interferon/ribavirin combination therapy in genotype 1b chronic hepatitis C.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 Aug 2014
Atsukawa Masanori, Tsubota Akihito, Shimada Noritomo, Abe Hiroshi, Kondo Chisa, Itokawa Norio, Nakagawa Ai, Iwakiri Katsuhiko, Kawamoto Chiaki, Aizawa Yoshio, Sakamoto Choitsu
Abstract excerpt
BACKGROUND: Close relationships between chronic hepatitis C and vitamin D levels have been reported. For genotype 1b infection, the current standard of care is pegylated interferon/ribavirin therapy combined with a protease inhibitor. The present study analyzed the relationship between outcomes of triple therapy and serum 25(OH)D3 levels. METHODS: Factors contributing to sustained virological response were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
